Found 61 clinical trials
Measuring Impairment with Novel Digital Signals (MINDS2021)
Achievement Studies supports a mission of empowering everyone to participate in better health outcomes. In this 6-month sponsored study, we’re interested in learning more about people with memory problems and how their lives are different from people without memory problems. Approximately 300 individuals will participate. There will be two groups: …
- 80 views
- 27 May, 2022
- 1 location
- Online study
A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)
Welcome to TogetherA study for memory loss If you are concerned about changes to your memory, joining the Together clinical study might be a suitable option for you. To qualify for this study, you must:· Be between 50 and 80 years old· Have mild memory problems or early Alzheimer’s disease· Meet some additional study criteria The …
- 1 views
- 17 May, 2022
- 85 locations
![A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Gantenerumab in Patients with Early [Prodromal to Mild] Alzheimer's Disease](/media/imagery/227902.svg)
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study of Gantenerumab in Patients with Early [Prodromal to Mild] Alzheimer's Disease
Studies the effect of a new drug in Early Alzheimer's
- 34 views
- 08 Dec, 2020
- 1 location
Mild Dementia/Alzheimer's Disease
Mild Dementia/Alzheimer's Disease
- 474 views
- 25 Mar, 2021
- 1 location
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
ADvance II: A 12-month Double-blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Deep Brain Stimulation of the Fornix (DBS-f) in Patients With Mild Probable Alzheimer's Disease
- 0 views
- 22 Nov, 2021
- 12 locations
- 87 views
- 25 Mar, 2021
- 1 location
Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of Piromelatine in Patients With Mild Dementia Due to Alzheimer's Disease.
Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose Ranging Study of Piromelatine in Patients With Mild Dementia Due to Alzheimer's Disease.
- 104 views
- 08 Dec, 2020
- 1 location
Is your memory loss just a sign of age, or something else?
Is your memory loss just a sign of age, or something else?
- 446 views
- 08 Dec, 2020
- 1 location
Alzheimer's Disease Center Research Registry
This study is looking for people over the age of 55 who have normal cognition, memory problems, or mild dementia. The study is also looking for people who are care partners of someone who has
- 224 views
- 14 Apr, 2022
- 1 location
- Online study